title: Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
abstract: Selection of the optimal surgical and interventional therapies for advanced colorectal cancer liver metastases (CRLM) requires multidisciplinary discussion of treatment strategies early in the trajectory of the individual patient's care. This paper reports on expert consensus on locoregional and interventional therapies for the treatment of advanced CRLM. Resection remains the reference treatment for patients with bilateral CRLM and synchronous presentation of primary and metastatic cancer. Patients with oligonodular bilateral CRLM may be candidates for one-stage multiple segmentectomies; two-stage resection with or without portal vein embolization may allow complete resection in patients with more advanced disease. After downsizing with preoperative systemic and/or regional therapy, curative-intent hepatectomy requires resection of all initial and currently known sites of disease; debulking procedures are not recommended. Many patients with synchronous primary disease and CRLM can safely undergo simultaneous resection of all disease. Staged resections should be considered for patients in whom the volume of the future liver remnant is anticipated to be marginal or inadequate, who have significant medical comorbid condition(s), or in whom extensive resections are required for the primary cancer and/or CRLM. Priority for liver-first or primary-first resection should depend on primary tumour-related symptoms or concern for the progression of marginally resectable CRLM during treatment of the primary disease. Chemotherapy delivered by hepatic arterial infusion represents a valid option in patients with liver-only disease, although it is best delivered in experienced centres. Ablation strategies are not recommended as first-line treatments for resectable CRLM alone or in combination with resection because of high local failure rates and limitations related to tumour size, multiplicity and intrahepatic location.
authors.affiliation: Department of Surgery, Lebanese American University, Beirut, Lebanon. eabdalla@lau.edu.lb
authors.forename: Eddie K
authors.initials: EK
authors.lastname: Abdalla
authors.forename: Todd W
authors.initials: TW
authors.lastname: Bauer
authors.forename: Yun S
authors.initials: YS
authors.lastname: Chun
authors.forename: Michael
authors.initials: M
authors.lastname: D'Angelica
authors.forename: David A
authors.initials: DA
authors.lastname: Kooby
authors.forename: William R
authors.initials: WR
authors.lastname: Jarnagin
mesh_terms: D059186:Chemoradiotherapy, Adjuvant / Q000379:methods; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000628:therapy*; D003245:Consensus Statements as Topic; D004621:Embolization, Therapeutic; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D033183:Interdisciplinary Communication; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy*; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome